TFEB, as an important regulator of autophagy and lysosome, also presents a significant decrease in AD, and the targeted activation of TFEB can effectively activate autophagy, improve the autophagy-lysosomal pathway, reduce APP, Aβ, tau protein and improve learning and memory ability in mice [37,38]. Here, APP is linked to Alzheimer disease.